Loading

Celebrating Women Leading Innovation in Biopharma

June 18, 2025
Breakout Session
Diversity and Opportunity
208
Recent data reveals that less than 10% of CEOs in the biopharma industry are women, while female representation in leadership teams stands at 25%. However, the momentum for change is undeniable. A growing number of female leaders are driving innovation and shaping the future of healthcare, demonstrating the powerful impact of women at the forefront of the industry. This panel will spotlight glass shattering female CEOs who are not just leading biotech companies - they are reshaping the future of healthcare. These leaders are leveraging their unique perspectives to foster innovation, develop patient-focused solutions, and push their companies forward in an increasingly competitive industry. Attendees will gain firsthand insights into the pivotal moments and bold decisions that have propelled these leaders to the forefront of biopharma. From startup funding to empowering women in life sciences and tackling gender disparities in research and healthcare, this panel will explore how female-led innovation is transforming healthcare and setting new standards for excellence.
Moderator
Nicole DeFeudis
Editor
Endpoints News
Speakers
Judy Chou, PhD
President and CEO
AltruBio
Angela Hwang, MBA
CEO
Metaphore Biotechnologies
Elizabeth Jeffords
President & CEO
Iolyx Therapeutics
Sabrina M. Johnson
President and CEO
Daré Bioscience
Daisy Robinton, PhD
Co-Founder & CEO
Oviva Therapeutics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS